J-GLOBAL ID:201701005891582393   Update date: Dec. 24, 2019


イノウエ ヤステル | INOUE YASUTERU
Affiliation and department:
Research field  (1): Neurology
Research theme for competitive and other funds  (1):
  • 2018 - 2019 Proteomics-based approaches for identification of novel molecules for early diagnosis and treatments of cerebral amyloid angiopathy in transthyretin-related familial amyloid polyneuropathy
Papers (30):
  • Misumi Y, Ueda M, Masuda T, Tsuda Y, Nomura T, Okada M, Inoue Y, Tasaki M, Obayashi K, Yamashita T, Ando Y. Characteristics of acquired transthyretin amyloidosis: A case series and review of the literature. Neurology. 2019. 93. 17. e1587-e1596
  • Inoue Y, Ueda M, Masuda T, Misumi Y, Yamashita T, Ando Y. Memantine, a Noncompetitive N-Methyl-D-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression. Molecular neurobiology. 2019. 56. 12. 8573-8588
  • Yamashita T, Ueda M, Nomura T, Okazaki T, Okada M, Tsuda Y, Inoue Y, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Inomata Y, Hibi T, Ando Y. Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis. Neurology. 2019. 93. 16. 714-716
  • Ueda M, Okada M, Mizuguchi M, Kluve-Beckerman B, Kanenawa K, Isoguchi A, Misumi Y, Tasaki M, Ueda A, Kanai A, Sasaki R, Masuda T, Inoue Y, Nomura T, Shinriki S, Shuto T, Kai H, Yamashita T, Matsui H, Benson MD, Ando Y. A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH. The Journal of biological chemistry. 2019
  • Nomura T, Ueda M, Tasaki M, Misumi Y, Masuda T, Inoue Y, Tsuda Y, Okada M, Okazaki T, Kanenawa K, Isoguchi A, Nakamura M, Obayashi K, Shinriki S, Matsui H, Yamashita T, Ando Y. New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis. Orphanet journal of rare diseases. 2019. 14. 1. 116
MISC (12):
  • 井上 泰輝, 植田 光晴, 増田 曜章, 三隅 洋平, 山下 太郎, 安東 由喜雄. メマンチン塩酸塩はインスリン分解酵素の発現上昇を介し脳アミロイド血管症を抑制する. Dementia Japan. 2019. 33. 4. 518-518
  • 井上 泰輝, 安東 由喜雄. 【指定難病ペディア 2019】個別の指定難病 代謝・内分泌系 全身性アミロイドーシス[指定難病28]. 日本医師会雑誌. 2019. 148. 特別1. S258-S260
  • 井上泰輝, 植田光晴. 脳アミロイドアンギオパチーの新規病態関連分子SRPX1. 医学のあゆみ. 2018. 266. 4. 295-296
  • 植田 光晴, 三隅 洋平, 増田 曜章, 津田 幸元, 井上 泰輝, 野村 隼也, 山下 太郎, 安東 由喜雄. トランスサイレチンフラグメントのアミロイド形成および細胞毒性の解析. 末梢神経. 2018. 29. 1. 42-49
  • 植田 光晴, 水口 峰之, 三隅 洋平, 増田 曜章, 津田 幸元, 田崎 雅義, 松本 紗也加, 水上 真由美, 末永 元輝, 井上 泰輝, 木下 祐美子, 野村 隼也, 山下 太郎, 大林 光念, 安東 由喜雄. 家族性アミロイドポリニューロパチーにおけるアミロイド形成過程の解析. 自律神経. 2017. 54. 2. 162-162
Lectures and oral presentations  (7):
  • Wake-Up Intracerebral Hemorrhage: Clinical characteristics, hematoma features, and outcomes.
    (European Stroke Conference, May22-25, Lisbon, Portugal 2011)
  • inical profiles of intracerebral hemorrhage in high-aged patients
    (European Stroke Conference 2012)
  • Diagnostic Significance of Cortical Superficial Siderosis for Alzheimer’s Disease in Patients with Cognitive Impairment.
    (International CAA conference, 2014)
  • Clinicopathological and proteomic analyses of sporadic cerebral amyloid angiopathy.
    (XIV International Symposium on Amyloidosis 2014)
  • Point-of-Purchase Stroke Educational Campaign at Supermarket is Effective for Rural Residents
    (nternational Stroke Conference 2014. 2014)
Awards (1):
  • 2018/01 - 「Kumamoto Best Neuro-Basic Study Award」
Association Membership(s) (4):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page